• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子水平上深入研究高三尖杉酯碱抑制 SARS-CoV-2 进入相关必需蛋白的作用机制。

Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry.

机构信息

MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, School of Physics, Xi'an Jiaotong University, Xi'an 710049, China; School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.

MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, School of Physics, Xi'an Jiaotong University, Xi'an 710049, China.

出版信息

Int J Biol Macromol. 2023 Jun 15;240:124352. doi: 10.1016/j.ijbiomac.2023.124352. Epub 2023 Apr 11.

DOI:10.1016/j.ijbiomac.2023.124352
PMID:37054859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10085973/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently posed a serious threat to global public health. Harringtonine (HT), as a small-molecule antagonist, has antiviral activity against a variety of viruses. There is evidence that HT can inhibit the SARS-CoV-2 entry into host cells by blocking the Spike protein and transmembrane protease serine 2 (TMPRSS2). However, the molecular mechanism underlying the inhibition effect of HT is largely elusive. Here, docking and all-atom molecular dynamics simulations were used to investigate the mechanism of HT against the receptor binding domain (RBD) of Spike, TMPRSS2, as well as the complex of RBD and angiotensin-converting enzyme 2 complex (RBD-ACE2). The results reveal that HT binds to all proteins primarily through hydrogen bond and hydrophobic interactions. Binding with HT influences the structural stability and dynamic motility processes of each protein. The interactions of HT with residues N33, H34 and K353 of ACE2, and residue K417 and Y453 of RBD contribute to disrupting the binding affinity between RBD and ACE2, which may hinder the virus entry into host cells. Our research provides molecular insights into the inhibition mechanism of HT against SARS-CoV-2 associated proteins, which will help for the novel antiviral drugs development.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)最近对全球公共卫生构成了严重威胁。作为一种小分子拮抗剂,高三尖杉酯碱(HT)对多种病毒具有抗病毒活性。有证据表明,HT 通过阻断刺突蛋白和跨膜丝氨酸蛋白酶 2(TMPRSS2)来抑制 SARS-CoV-2 进入宿主细胞。然而,HT 抑制作用的分子机制在很大程度上仍不清楚。在这里,我们使用对接和全原子分子动力学模拟来研究 HT 针对 Spike 的受体结合域(RBD)、TMPRSS2 以及 RBD 和血管紧张素转换酶 2 复合物(RBD-ACE2)复合物的抑制机制。结果表明,HT 主要通过氢键和疏水相互作用与所有蛋白质结合。与 HT 的结合影响每个蛋白质的结构稳定性和动态运动过程。HT 与 ACE2 的残基 N33、H34 和 K353 以及 RBD 的残基 K417 和 Y453 的相互作用有助于破坏 RBD 和 ACE2 之间的结合亲和力,这可能阻碍病毒进入宿主细胞。我们的研究为 HT 抑制 SARS-CoV-2 相关蛋白的机制提供了分子见解,这将有助于开发新型抗病毒药物。

相似文献

1
Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry.分子水平上深入研究高三尖杉酯碱抑制 SARS-CoV-2 进入相关必需蛋白的作用机制。
Int J Biol Macromol. 2023 Jun 15;240:124352. doi: 10.1016/j.ijbiomac.2023.124352. Epub 2023 Apr 11.
2
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
3
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.木犀草素抑制严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转化酶 2 的结合。
Phytother Res. 2023 Aug;37(8):3508-3521. doi: 10.1002/ptr.7826. Epub 2023 May 11.
4
Withanone from Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model.Withanone 抑制 SARS-CoV-2 RBD 与宿主 ACE2 的相互作用,挽救人源化斑马鱼模型中 Spike 蛋白诱导的病理损伤。
Drug Des Devel Ther. 2021 Mar 11;15:1111-1133. doi: 10.2147/DDDT.S292805. eCollection 2021.
5
Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.维生素 D3 及其羟基衍生物作为有前途的 COVID-19 治疗药物:一项计算研究。
J Biomol Struct Dyn. 2022;40(22):11594-11610. doi: 10.1080/07391102.2021.1964601. Epub 2021 Aug 20.
6
Synthesis and anti-SARS-CoV-2 activity of amino acid modified cephalotaxine derivatives.氨基酸修饰的三尖杉酯碱衍生物的合成及抗 SARS-CoV-2 活性。
Chem Biol Drug Des. 2024 Jun;103(6):e14566. doi: 10.1111/cbdd.14566.
7
Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.鞣酸与 SARS-CoV-2 感染性相关蛋白的分子相互作用。
Int J Mol Sci. 2022 Feb 27;23(5):2643. doi: 10.3390/ijms23052643.
8
Harringtonine metabolites: 5'-de-O-methylharringtonine and cephalotaxine, targeting spike protein and TMPRSS2 to double block membrane fusion of SARS-CoV-2 and its variants.高三尖杉酯碱代谢物:5'-去 O-甲基高三尖杉酯碱和 Cephalotaxine,靶向刺突蛋白和 TMPRSS2 双重阻断 SARS-CoV-2 及其变体的膜融合。
Eur J Pharmacol. 2024 Nov 15;983:177012. doi: 10.1016/j.ejphar.2024.177012. Epub 2024 Sep 18.
9
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.多学科方法鉴定与人 ACE2 或 SARS-CoV-2 刺突蛋白结合的化合物,作为阻断 SARS-CoV-2-ACE2 受体相互作用的候选药物。
mBio. 2021 Mar 30;12(2):e03681-20. doi: 10.1128/mBio.03681-20.
10
Tinocordiside from (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain.(吉尔勒)中的新化合物 Tinocordiside 可能通过破坏宿主 ACE2 和病毒 S-蛋白受体结合域之间的静电相互作用来抑制 SARS-CoV-2 的传播。
Comb Chem High Throughput Screen. 2021;24(10):1795-1802. doi: 10.2174/1386207323666201110152615.

引用本文的文献

1
Molecular insight into binding affinities and blockade effects of selected flavonoid compounds on the PD-1/PD-L1 pathway.对选定类黄酮化合物与PD-1/PD-L1通路的结合亲和力和阻断作用的分子洞察。
RSC Adv. 2024 Aug 16;14(36):25908-25917. doi: 10.1039/d4ra03877k.

本文引用的文献

1
Rapid Structure-Based Screening Informs Potential Agents for Coronavirus Disease (COVID-19) Outbreak.基于结构的快速筛选为冠状病毒病(COVID-19)疫情提供潜在药物。
Chin Phys Lett. 2020 May;37(5):058701. doi: 10.1088/0256-307X/37/5/058701.
2
Emerging SARS-CoV-2 variants: Why, how, and what's next?新型严重急性呼吸综合征冠状病毒2变体:成因、方式及后续情况?
Cell Insight. 2022 May 2;1(3):100029. doi: 10.1016/j.cellin.2022.100029. eCollection 2022 Jun.
3
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.令人担忧的 SARS-CoV-2 BQ 和 XBB 亚型不断出现的抗体逃逸特性。
Cell. 2023 Jan 19;186(2):279-286.e8. doi: 10.1016/j.cell.2022.12.018. Epub 2022 Dec 14.
4
Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.抑制 SARS-CoV-2 的非结构蛋白 15:计算研究
Cell Biochem Funct. 2022 Dec;40(8):926-934. doi: 10.1002/cbf.3753. Epub 2022 Oct 6.
5
Recognition between CD147 and cyclophilin A deciphered by accelerated molecular dynamics simulations.通过加速分子动力学模拟揭示 CD147 与亲环素 A 之间的识别。
Phys Chem Chem Phys. 2022 Aug 10;24(31):18905-18914. doi: 10.1039/d2cp01975b.
6
In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing.基于计算机的 SARS-CoV-2 NSP6 靶向治疗用于药物和天然产物的再利用。
Virology. 2022 Aug;573:96-110. doi: 10.1016/j.virol.2022.06.008. Epub 2022 Jun 15.
7
Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation.与新冠病毒激活相关的人类跨膜丝氨酸蛋白酶2(TMPRSS2)的结构与活性
Nat Chem Biol. 2022 Sep;18(9):963-971. doi: 10.1038/s41589-022-01059-7. Epub 2022 Jun 8.
8
Computational identification of potential chemoprophylactic agents according to dynamic behavior of peroxisome proliferator-activated receptor gamma.根据过氧化物酶体增殖物激活受体γ的动态行为对潜在化学预防剂进行计算识别。
RSC Adv. 2020 Dec 22;11(1):147-159. doi: 10.1039/d0ra09059j. eCollection 2020 Dec 21.
9
Homo-harringtonine, highly effective against coronaviruses, is safe in treating COVID-19 by nebulization.高三尖杉酯碱对冠状病毒高效,通过雾化吸入治疗新冠病毒肺炎是安全的。
Sci China Life Sci. 2022 Jun;65(6):1263-1266. doi: 10.1007/s11427-021-2093-2. Epub 2022 Mar 22.
10
Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review.正在进行的SARS-CoV-2临床试验中小分子药物的作用机制:综述。
Front Pharmacol. 2022 Feb 25;13:840639. doi: 10.3389/fphar.2022.840639. eCollection 2022.